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Parkinson's disease is a neurodegenerative disorder characterized by the formation of Lewy bodies
containing aggregated α-synuclein. We used a yeast model to screen for deletion mutants with
mislocalization and enhanced inclusion formation of α-synuclein. Many of the mutants were affected in
functions related to vesicular trafﬁc but especially mutants in endocytosis and vacuolar degradation
combined inclusion formation with enhanced α-synuclein-mediated toxicity. The screening also allowed for
identiﬁcation of casein kinases responsible for α-synuclein phosphorylation at the plasma membrane as well
as transacetylases that modulate the α-synuclein membrane interaction. In addition, α-synuclein was found
to associate with lipid rafts, a phenomenon dependent on the ergosterol content. Together, our data suggest
that toxicity of α-synuclein in yeast is at least in part associated with endocytosis of the protein, vesicular
recycling back to the plasma membrane and vacuolar fusion defects, each contributing to the obstruction of
different vesicular trafﬁcking routes.
1. Introduction
Parkinson's disease (PD) is a common neurodegenerative move-
ment disorder characterized by the selective loss of dopaminergic
neurons in the substantia nigra pars compacta and the formation of
proteinacious cytoplasmic inclusions in the affected neurons. These
inclusions are known as Lewy bodies and are mainly composed of
ﬁbrillar α-synuclein (α-Syn) [1]. Familial forms of PD are associated
with missense mutations (A30P, A53T and E46K) in the α-Syn gene, as
well as duplication or triplication of the α-Syn locus, i.e. genetic
alterations that accelerate α-Syn misfolding and aggregation [2]. The
exact molecular mechanisms that induce misfolding and toxicity ofα-
Syn, especially in the more common sporadic forms of PD, are still
elusive though several observations point to modiﬁcations such as C-
terminal truncation, oxidation and phosphorylation or aberrant
interactions with normal binding partners as possible causes [1,2].
Also, the function of α-Syn is far from clear due to its apparent
involvement in many cellular processes. However, converging obser-
vations suggest a role as regulator of dopamine neurotransmission
and synaptic vesicular recycling [3]. A recent study with transgenic
mice deﬁcient for the cysteine-string protein-α demonstrated that
human α-Syn can ameliorate complex assembly between plasma
membrane and vesicular SNARE proteins. Interestingly, this activity
depended on the capacity of α-Syn to interact with phospholipids and
hence was observed with wild type α-Syn, but not with the A30P
mutant [4]. Moreover, a study performed in PC12 cells led to the
conclusion that α-Syn has a role in a vesicle “priming” step, after
secretory vesicle trafﬁcking to “docking” sites, but before calcium-
dependent vesicle membrane fusion [5].
Previously, we and others validated the yeast Saccharomyces
cerevisiae as model system to study the biochemistry and toxicity of
α-Syn. Reminiscent to data produced by other models, the yeast
system showed thatα-Syn localized to the plasmamembrane, formed
intracellular inclusions, and inhibited phospholipase D [6–8]. We
extended these data and demonstrated that the formation of
inclusions by wild type α-synuclein (WT-Syn) and the clinical mutant
A53T is a nucleation–elongation process initiated at the plasma
membrane. Moreover, the failure of mutant A30P to form such
inclusions could be attributed to its lower afﬁnity for phospholipids
since also this mutant formed aggregates when co-expressed with
WT-Syn, which apparently formed the membrane-localized seeds
necessary to induce the aggregation process [7]. Most interestingly,
Cooper et al. [9] identiﬁed vesicular trafﬁcking between the
endoplasmic reticulum (ER) and Golgi as an early defect observed in
yeast cells following expression of WT-Syn. Encouraged by these data
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and the observation of synthetic lethality induced by α-Syn in some
yeast mutants affected in protein sorting [8,10], we performed a
genome-wide screening to isolate yeast deletion mutants that are
characterized bymislocalization and/or enhanced inclusion formation
of WT-Syn. This study led us to identify of several yeast orthologs and
homologs of human proteins involved in vesicular transport and to
demonstrate α-Syn phosphorylation, N-terminal acetylation and lipid
raft interaction as well as parameters determining α-Syn toxicity in
yeast.
2. Materials and methods
2.1. Yeast strains, plasmids and media
In this study we used the wild type BY4741 (MATa his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) strain and its congenic deletion mutants [11]. The
pUG23-syn plasmids for expression of α-Syn from the methionine-
repressible MET25 promoter as well as the YEp181-syn plasmids for
constitutive expression of α-Syn were described previously [7]. The
pUG35-syn plasmids were obtained by ligation of an XbaI and SalI
fragment corresponding to the cDNA's of wild type α-Syn or the
mutants A53T or A30P from the pUG23-syn plasmids into pUG35 cut
with the same restriction enzymes. Transformation procedures
followed the standard lithium/polyethylene glycol method [12].
Transformants were grown at 30 °C in selective minimal glucose-
containing medium (SD — Synthetic Dextrose) [12] supplemented
with 1 mM methionine to suppress expression of α-Syn, 20 μM
methionine to obtain moderate expression of α-Syn, or without
methionine to obtain overexpression of α-Syn.
2.2. Determination α-Syn-mediated growth retardation
In order to test growth retardation caused by native α-Syn, the
growth proﬁles of the strains transformed with an empty vector or a
YEp181 plasmid allowing for constitutive expression of WT-Syn were
compared. Overnight precultures of three independent transformants
were used to inoculate new cultures in glucose-containing synthetic
medium at a starting OD600 of 0.05. The growth proﬁles were then
established by measuring OD600 until the stationary phase was
reached. Based on the log-transformed growth proﬁles, we calculated
the half-times for growth of each mutant, i.e the time necessary to
reach half-maximal OD600, and took the difference in time (ΔT) when
the strain was expressing native WT-Syn or transformed with the
control plasmid.
2.3. Genome-wide screening of S. cerevisiae to identify genes important
for α-Syn–EGFP fusion localization in the cell
The S. cerevisiae deletion strain collection, constructed in the
BY4741 background (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0), was
obtained from Euroscarf (Frankfurt, Germany). Each deletion strain (of
a total of 4,857 viable strains available in the library) carries a
replacement of a characterized or putative ORF by a kanMX4 marker
construct. Double mutants were obtained by crossing and subsequent
tetrad analysis. The method for transformation of pUG35WT-syn
plasmid into the yeast knockout collection and further selection was
described previously [13].
To identify genes whose products are involved in localization of
WT-Syn–EGFP fusion, the transformed collection was replica plated
on SD plates containing 0.3 mM methionine. Each colony was then
transferred to liquid medium without methionine and cells were
grown till exponential phase. Each culture was subsequently
inspected by ﬂuorescent microscopy to observe localization of
WT-Syn–EGFP. This screening was performed in duplicate. Mis-
localization of WT-Syn–EGFP was further conﬁrmed in the BY4741
strain transformed with pUG35WT-syn or pUG23WT-syn and
grown in SD medium containing 20 μM methionine as described
previously [7].
2.4. Antibodies and immunoblot analysis
α-Synuclein was detected with a rabbit polyclonal antibody
directed against the C-terminus (Sigma) or an antibody speciﬁc for
phosphorylated ser-129 (Wako, Japan).
Samples for Western blot analysis were prepared according to
Zabrocki and coauthors [7]. Proteins were then separated by SDS-
PAGE. To equilibrate the amount of protein, we compared the
intensities obtained from Ponceau S staining of Immobilon-P (Milli-
pore) after transfer of the proteins from gel to the ﬁlter, as well as by
detection of ADH2 expression (anti-ADH2 antibody, Chemicon/Milli-
pore, USA) that served as internal control of protein content. The
antibody directed against Pma1 was a gift from B. André (ULB,
Belgium).
Immunoreactions were quantiﬁed using TINA 2.08c program
(Raytest, Belmont, USA). The immunoreactivity of phosphorylated
α-Syn was normalized against the signal obtained for the total
amount of α-Syn using the polyclonal anti-synuclein antibody.
Experiments were done at least in duplicate with different
transformants.
2.5. Microscopy
Fluorescence microscopy was performed with the OptiPhot
(Nikon, Japan) microscope. Transformants with theMET25-controlled
expression cassettes for EGFP-fused α-Synwere cultured overnight in
selective medium containing 1 mMmethionine. From this preculture,
cells were taken to inoculate a second culture (starting OD600=0.1) in
selectivemedium containing 20 μMmethionine and incubated for 16–
18 h at 30 °C (unless otherwise indicated) as described previously [7].
Cells were observed with the M-Plan 100×/oil objective lens and the
ﬁlter set with excitation ﬁlter 470 nm and 520LP emission ﬁlter
(Nikon, Japan). The proportion of cells with the α-Syn mislocalization
within the population was then determined by inspection of at least
200 cells per culture.
For endocytosis of FM4-64 and visualization of vacuoles, yeast
strains were grown in 50 ml of SD with 20 μM methionine till
OD600=1. Cells were harvested, washed in fresh medium and stained
with 18 μM FM4-64 dye (Molecular Probes) as it was described
previously [7]. Vacuoles were visualized using 525/590LP ﬁlter set
(Nikon, Japan) and counted manually. Cells with small clustered
vacuoles were considered to have a vacuolar fusion defect.
2.6. Isolation of detergent-resistant lipid raft fractions
An amount equivalent to OD600 20 was taken of exponentially
grown yeast cultures to perform the isolation of lipid raft fractions.
The exponential cells were washed once with chilled water and lysed
using a standard protocol with glass beads. Lysis was performed in
TNE buffer (50 mM Tris–HCl, pH7.4, 150 mM NaCl and 5 mM EDTA)
with addition of proteases inhibitors (benzamidine, PMSF and a
cocktail of protease inhibitors (Roche)) [14]. Lysates were centrifuged
at 500 g for 5 min at 4 °C, split in two parts. Triton-X-100 was added
to 0.2% (or 1%, data not shown) to one part while TNE was added to
the second part. Lysates were incubated on ice for 30 min, mixed
with OptiPrep (Sigma) solution to reach 35% concentration and then
overlaid with 1.2 ml of 30% OptiPrep solution in TXNE (TNE
containing 0.1% Triton-X-100) and subsequently with 200 μl of
TXNE. The samples were centrifuged at 259 000 g for 8 h at 4 °C in
SW55Ti rotor (Beckman, USA). Eleven equal fractions were taken and
every fraction was precipitated by adding 50% trichloroacetic acid.
Samples were centrifuged and protein pellets resuspended in
2×SDS-PAGE buffer and loaded on SDS-PAGE gel. Equal volumes of
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particular fractions were analyzed by SDS-PAGE and Western
blotting.
3. Results
3.1. Mislocalization of α-Syn in yeast mutants
It was previously demonstrated that expression of a WT-Syn–EGFP
C-terminal fusion protein in yeast cells leads to the formation of
amyloidic inclusions, similarly to expression of nativeα-Syn [6–8].We
took advantage of this ability to screen the genome-wide collection of
yeast deletion strains with ﬂuorescence microscopy to identify
mutants that display mislocalization and/or enhanced inclusion
formation as compared to the congenic wild type BY4741 yeast strain,
when tested under conditions where the latter shows plasma
membrane localization of the WT-Syn–EGFP fusion. As listed in
Table S1 (Supplemental material) and quantiﬁed in Fig. 1, the
screening retrieved 185 mutants that showed mislocalization of the
fusion protein often together withmore cells formingα-Syn inclusion.
Consistent with previous observations, these inclusions were either
dense or more diffuse and in some mutants clearly vesicular
membrane associated [7,15]. It should be noted that the amount of
cells that formed α-Syn inclusions varied considerably between
mutants, ranging up to 95% in a mutant like vps33Δ as compared to
about 2% in the congenic wild type.
Dependent on the role of the gene deleted, the mutants were
classiﬁed into functional groups (Fig. 1; Table S1—Supplemental
material). This revealed that several mutants appeared to be affected
in protein degradation or were lacking chaperones or proteins
involved in the ubiquitin–proteasome system. Other mutants were
missing proteins involved in oxidative stress responses, including
mitochondrial functions or proteins involved in glutathione metabo-
lism. As such, our screening selected relevant mutants as indeed
several recent studies performed in other model systems as well as on
Parkinson patients implicated failure to properly degrade misfolded
proteins, mitochondrial dysfunction and oxidative stress as important
factors in the etiology of PD [16]. Previous studies in yeast also pointed
to reciprocal effects between these processes and α-Syn [7,10,17–21],
providing further conﬁdence that relevant mutants were selected.
Nonetheless, the majority of mutants selected by our screening were
affected in processes connected to vesicular trafﬁc and protein sorting.
This included not only strains lacking proteins involved in endocytosis,
the secretory pathway or the vacuolar protein sorting (VPS) pathway
but also strains defective in vacuolar biogenesis, cytosol-to-vacuole
transport (cvt), actin organization as well as the metabolism and
signaling of phospholipids, sterols and inositides. Interestingly, seven
of these mutants were previously identiﬁed based on a genome-wide
screening for yeast mutants that are synthetic sick or lethal upon
expression of α-Syn [10]. This included arl3Δ, cog6Δ, sac2, vps24Δ,
vps28Δ and vps60Δ, which all lack functions directly involved in
vesicular trafﬁc, and opi3Δ, which is affected in phospholipid
metabolism. Also proteins that potentially modulate α-Syn-induced
dysfunction of ERAD (ER-Associated Degradation) and ER-stress [9]
were recovered by our screening, including Erv29, an ER cargo
receptor, and Gyp1, a GAP protein known to regulate the Rab GTPase
Ypt1.
Since recent studies indicated that α-Syn has roles in lipid
metabolism and vesicle dynamics [3–5], we mainly focused on related
Fig. 1. Strains retrieved from the genome-wide screening for mutants with mislocalization and enhanced inclusion formation of α-Syn. Shown is a bar diagram representing the
relative number of cells with WT-Syn–EGFP inclusions (% of the total number of cells in the culture). The numbering of the different mutants corresponds to those given in Table S1
(Supplemental material). Also indicated is the process in which each mutant is affected.
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functions in yeast. Pictures displaying the intracellular distribution of
the WT-Syn–EGFP fusion in mutants discussed in more detail in this
paper are given in Fig. 2.
3.2. Phosphorylation of α-Syn in yeast is mediated by plasma membrane
casein kinases and correlates with its inclusion formation and toxicity
Among the genes involved in lipid metabolism and signaling our
screening identiﬁed Ckb1 and Ckb2, the regulatory subunits that
control substrate speciﬁcity of the yeast casein kinase II (CK-II). The
catalytic subunits of CK-II are redundantly encoded by CKA1 and CKA2
[22]. CK-II kinases are essential for growth and besides their role in
transducing survival signals, they appear to have a function in
phospholipid and ceramide synthesis [23–25]. As shown in Fig. 2,
the deletion of each of the regulatory subunits caused a similar
phenotype with WT-Syn–EGFP not only being present at the plasma
membrane but also in foci that may correspond to the ER and Golgi
complex [23]. Mutants for the catalytic CK-II subunits were not
retrieved by our screening and a more thorough analysis conﬁrmed
that these strains did not give rise to a clear mislocalization phenotype
as WT-Syn–EGFP remained predominantly at the plasma membrane,
similar as in the congenic wild type strain (data not shown).
Also the casein kinase I (CK-I) Yck3 was retrieved by our screen.
Yck3 is known to regulate the Vps/HOPS (Homotypic Fusion and
Vacuole Protein Sorting) complex required for homotypic vacuolar
fusion and fusion of transport vesicles to the vacuole [26–28].
Fig. 2. Mislocalization and inclusion formation of α-Syn in speciﬁed yeast mutants. (A) Fluorescence microscopic visualization and intracellular localization of the WT-Syn–EGFP
fusion protein in the BY4741 wild type yeast strain (BY4741WT) and the congenic deletion mutants that are discussed in more detail in this paper. The mutants were ordered
according the functions in which they are affected. Categories include mutants lacking protein kinases (ckb1Δ, ckb2Δ, yck3Δ, yck2Δ, yck1Δ and ypk1Δ), vesicular trafﬁcking mutants
(doa4Δ, vps36Δ, vps21Δ, pep12Δ, vps33Δ, vps28Δ and vps45Δ) and mutants affected in N-terminal acetyltransferase activities (nat3Δ, mdm20Δ, mak3Δ and yir042cΔ). For the
yir042cΔ mutant the arrows indicate association of the WT-Syn–EGFP fusion protein with the vacuolar membrane. (B) Overlay of WT-Syn–EGFP localization and endocytosed FM
4-64 in the yck3Δ mutant showing accumulation of α-Syn inclusions at the periphery of the vacuolar membrane.
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Consistently, its deletion caused enhanced α-Syn accumulation in
vesicles at the periphery of vacuoles as demonstrated by localization
of WT-Syn–EGFP in cells stained with the endocytosed dye FM4-64
(Fig. 2A and B). In addition to Yck3, the yeast genome encodes two
other CK-I kinases, i.e. Yck1 and Yck2, both localized at the plasma
membrane where they phosphorylate and mark proteins for subse-
quent ubiquitination and endocytosis [29]. In strains carrying a
deletion of YCK1 or YCK2, WT-Syn–EGFP remained at the plasma
membrane, similarly as in the wild type strain (data not shown).
Since CK-I and CK-II were reported to phosphorylate α-Syn at ser-
129 in vitro and in vivo in mammalian cells [30] and transgenic mice
[31], we examined whether casein kinases phosphorylated α-Syn in
yeast as well. First, we expressedWT-Syn or the clinical mutants A30P
or A53Tas EGFP fusion or native protein in the BY4741wild type strain
and analyzed the phosphorylation status of these proteins. Consistent
with previously reported data [6,7], the EGFP-tagged A53Twas plasma
membrane-localized, similar to WT-Syn–EGFP, while the EGFP-tagged
A30P mutant was predominantly cytoplasmic with only a minor
fraction at the plasma membrane (data not shown). Also consistent
was that WT-Syn and the A53T mutant are expressed at lower levels
when compared to the A30P mutant, as shown by Western blot
analysis of the native proteins obtained from exponentially growing
wild type cells (Fig. 3A). Subsequently, we analyzed ser-129
phosphorylation of α-Syn. This revealed that all α-Syn isoforms
were phosphorylated and that the level of phosphorylation of the
A30P mutant was signiﬁcantly lower than that of WT-Syn or the A53T
mutant (Fig. 3A). These data suggest an apparent positive correlation
between α-Syn phosphorylation, as reported here, and the ability to
bind the plasma membrane, form inclusions and to display toxicity in
yeast, as previously demonstrated [6,7]. Interestingly, overexposure of
the Western blots demonstrated that a fraction of the phosphorylated
α-Syn is also present as dimers in yeast, again with the lowest levels
obtained for the A30P mutant (Fig. 3B). Two independent studies
demonstrated that these α-Syn dimers preferentially bind lipid
membranes and vesicles in vitro and, consistent with our data, both
studies demonstrated reduced membrane binding of A30P as
compared to WT-Syn or A53T [32,33]. Note that these in vitro studies
were performed with recombinant non-phosphorylated α-Syn
obtained from bacteria, indicating that phosphorylation of α-Syn is
not a prerequisite for membrane binding.
Next, we analyzed the involvement of CK-I and CK-II for
phosphorylation of α-Syn. Therefore, we constitutively expressed
native WT-Syn in the corresponding yeast deletion mutants and
monitored again its phosphorylation during exponential growth.
Although the level of ser-129 phosphorylation was affected in each of
these mutants as compared to the congenic wild type strain, the most
dramatic decreases were observed in the strains missing Yck2, Cka2 or
Ckb2 (Fig. 3C). As control, a tpk2Δ mutant was included, which lacks
one of the catalytic PKA subunit. This mutant displayed ser-129
phosphorylation levels similar to that of the wild type strain. We also
analyzed whether decreased α-Syn phosphorylation, by the lack of
Yck2, would affect dimer-formation but could not observe any
signiﬁcant difference in the amount of α-Syn dimers formed in wild
type and yck2Δ cells (data not shown).
Given that phosphorylation of ser-129 deﬁnes α-Syn neurotoxicity
and inclusion formation in a Drosophila model and that it is
speciﬁcally associated toα-Syn aggregation in patients with Dementia
with Lewy Bodies (DLB) [34,35], we wondered whether lowering ser-
129 phosphorylation would ameliorate the α-Syn-induced toxicity in
our yeast model. To this end, we compared growth for the wild type
strain and the casein kinase mutants without or with expression of
native WT-Syn. To get a quantitative measurement that takes into
account possible growth differences speciﬁc for the yeast mutants, we
calculated the α-Syn-induced reduction in half-time for growth (ΔT)
for each strain; i.e. the difference in time necessary to reach the half-
maximal OD600 for a strainwhen constitutively expressing nativeWT-
Syn or when transformed with the control plasmid (Table 1). This
revealed that particularly the deletion of YCK1 and YCK2 reduced the
ΔT values. All other casein kinase mutants displayed higher ΔT values
as compared to thewild type strain. Thus, although both CK-I and CK-II
kinases affect ser-129 phosphorylation of WT-Syn in yeast, only
deletion of the plasma membrane-localized CK-I kinase ameliorated
growth of yeast cells expressing native WT-Syn.
Cells deprived of CK-I activity, such as yck1Δ yck2ts mutants at
restrictive temperature, were reported to show stabilization of
transporters and receptors at the plasma membrane, consistent with
a role of these casein kinases in the initial steps of endocytosis [36–
38]. Interestingly, CK-I deﬁcient cells display synthetic lethality when
combined with disruption of the clathrin heavy chain function,
suggesting that the CK-I kinases operate in an endocytic pathway
that is parallel to the clathrin-dependent pathway [36]. In line with
this, we found that the deletion of CHC1, encoding the clathrin heavy
chain, ameliorated the growth upon native WT-Syn expression to
similar extend as the deletion of YCK1 (Table 1), though the level of α-
Syn phosphorylation at ser-129 remained comparable to that
observed in wild type cells (Fig. 4). Reduced α-Syn toxicity was also
observed in cells lacking Rvs161, a member of the BAR-domain family
Fig. 3. Phosphorylation of α-Syn and the involvement of casein kinases. (A)
Phosphorylation of native WT-Syn and the clinical mutants A30P and A53T in the
wild type strain BY4741 as detected by immunodecoration using a phospho-ser129
speciﬁc monoclonal antibody and quantiﬁed relative to intensity obtained for
immunodetection with a polyclonal α-Syn antibody. (B) (Left) Detection of oligomeric
forms produced by native WT-Syn in the BY4741 wild type strain by Western blot
analysis of total protein extracts loaded at a ﬁnal amount of 5 μg and 10 μg using the
polyclonal α-Syn antibody. (Right) Detection of oligomeric forms produced by native
WT-Syn and the mutants A30P and A53T in BY4741 cells in total protein extracts loaded
at a ﬁnal amount of 10 μg using the monoclonal phospho-ser129 speciﬁc antibody. (C)
Quantiﬁcation of the relative amount of phosphorylation of native WT-syn in BY4741, a
control strain lacking the PKA subunit Tpk2 and mutants lacking a particular casein
kinase as indicated. The level of phosphorylation of WT-Syn in BY4741 was set at 100%.
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of proteins that includes amphiphysin (Table 1). In mammalian brain,
amphiphysins function in synaptic vesicle endocytosis where they
appear to sense membrane curvature and are involved in the release
of the forming vesicle [39,40]. In yeast, the Rvs proteins have been
attributed an additional role in targeting secretory vesicles to the
plasma membrane [41]. This may explain why the rsv161Δ displayed
comparable low α-Syn phosphorylation levels as the mutants lacking
CK-I kinases (Fig. 4), since indeed, WT-Syn was reported to reach the
plasma membrane via the secretory pathway [8].
Taken together, the picture emerging from the data described
above is that yeast mutants affected in the initial steps of endocytosis,
i.e. impaired CK-I-mediated phosphorylation events at the plasma
membrane or impaired formation and internalization of endocytic
vesicles, are characterized by a reduced α-Syn-induced toxicity.
3.3. Hampered endosomal transport and increased recycling results in
enhanced α-Syn phosphorylation and α-Syn toxicity
Recent studies demonstrated the serum- and glucocorticoid-
regulated kinase sgk1 to be associated with cell death in several
animal PD models [42]. Our screening recovered the SGK homologue
Ypk1 [43] as a protein kinase that upon deletion leads to accumulation
of α-Syn on intracellular and plasma membrane-localized vesicles
(Fig. 2). Ypk1 and its closely related kinase Ypk2 function in
sphingolipid signaling where they act downstream of the yeast
PDK1 orthologues Pkh1 and Pkh2, respectively [44]. Analysis of α-Syn
phosphorylation revealed that deletion of Pkh1 or its substrate Ypk1
resulted in increased levels of ser-129 phosphorylation while deletion
Pkh2 or Ypk2 yielded, respectively, similar and slightly reduced levels
as those observed for the wild type strain or the tpk2Δ control strain
(Fig. 4). This difference in phosphorylationwas reﬂected in the growth
properties of the mutants, as we found signiﬁcantly increased ΔT
values and enhanced α-Syn-mediated toxicity in the ypk1Δ mutant
strain in contrast to the ypk2Δmutant that displayed lower ΔT values
in comparison to the wild type strain (Table 1).
Both Ypk1 and Ypk2 play a role in endocytosis but despite their
close homology their functions appear not to be redundant. A recent
study on rapid ligand-induced internalization of the pheromone
receptor Ste2 established that Ypk2 is speciﬁcally required to
phosphorylate Myo5, a myosin I protein [45]. Myosins bear an actin-
activated ATPase and promote Arp2/3-dependent actin assembly
facilitating the formation and further invagination of clathrin coated
vesicle [46]. As such, Ypk2 appears to be involved in the initial steps of
vesicle formation and therefore it was not surprising that the ypk2Δ
mutant was characterized by a reduced α-Syn toxicity, similar as the
chc1Δ and rsv161Δ mutants described above (Table 1). The exact
point for interception of Ypk1 with endocytosis remains to be
determined. However, one study clearly demonstrated that it fulﬁls
functions that cannot be replaced by Ypk2 and which are downstream
of cargo phosphorylation and ubiquitination [47]. In addition, ypk1Δ
mutants were reported to be cold-sensitive and hypersensitive to
rapamycin, in contrast to ypk2Δ cells [44]. This link between Ypk1 and
rapamycin was conﬁrmed as the kinase associates with TORC1 and
TORC2 in a novel type of detergent-resistant membrane domains
(DRMs) distinct from plasma membrane rafts. Analysis of Ste3
internalization and liquid-phase endocytosis led these authors to
conclude that TORC1 is likely to function in a post-vesicle-internaliza-
tion step [48]. Based on this information, it is feasible that also Ypk1
operates after vesicle internalization. Therefore, we hypothesized that
the observed increased α-Syn toxicity that differentiates the ypk1Δ
mutant from the ypk2Δmutant (Table 1) relates to impaired trafﬁc of
the newly formed vesicle.
To reject or conﬁrm this hypothesis, we analyzed the mutant that
lacks the C-8 sterol isomerase Erg2. This mutant was also reported to
have a post-vesicle-internalization defect [49,50]. Our analysis
showed that the erg2Δ mutant combined increased α-Syn phosphor-
ylation with enhanced toxicity as well and thus had similar
characteristics as those of ypk1Δ cells upon expression of WT-Syn
(Table 1, Fig. 4). Other mutants affected in the downstream steps of
endocytosis revealed an equivalent phenotype (Table 1, Fig. 4). This
included strains lacking the Rab GTPase Vps21 or the t-SNARE Pep12/
Vps6, both class D Vps proteins involved in trafﬁc from early
endosomes to the prevacuolar compartment [51,52], the ESCRT-I
(Endosomal Sorting Complex Required for Transport) mutant lacking
Vps28, required in cargo selection for the vacuolar degradation/MVB
Fig. 4. Phosphorylation α-Syn in mutants affected in endocytosis or biosynthetic
protein sorting routes. Quantiﬁcation of the relative amount of phosphorylation of
native WT-Syn in BY4741, a control strain lacking the PKA subunit Tpk2 and mutants
lacking the PDK-orthologs Pkh1 or Pkh2 and the SGK-orthologs Ypk1 or Ypk2 as
indicated (left) or mutants lacking proteins involved in different vesicular trafﬁcking
routs as speciﬁed (right). The level of phosphorylation of WT-Syn in BY4741 was set
at 100%.
Table 1
Comparison of difference in the growth of yeast strains with or without overexpression
of WT-Syn
Strain ΔT±SEM [h]
BY4741 5.74±0.50
yck1Δ 3.54±0.12
yck2Δ 4.37±1.63
yck3Δ 6.96±1.48
tpk2Δ 5.23±0.97
cka1Δ 6.03±2.16
cka2Δ 8.35±2.17
ckb1Δ 7.39±0.76
ckb2Δ 6.24±0.68
ypk1Δ 11.69±1.87
ypk2Δ 2.47±0.67
doa4Δ 9.49±1.3
chc1Δ 3.25±2.33
erg2Δ 15.71±1.18
erg6Δ 5.45±0.95
nat1Δ 5.3±1.67
nat3Δ 0.94±1.68
pep12Δ 8.78±1.42
rvs161Δ 2.95±1.44
vps21Δ 9.67±1.96
vps28Δ 7.13±0.13
vps33Δ 4.40±1.60
vps45Δ 6,44±1.35
YIR042cΔ 6.66±0.16
vps21Δ vps33Δ 4.33±1.22
vps28Δ vps33Δ 4.75±1.75
vps21Δ yck1Δ 8.80±0.20
vps28Δ yck1Δ 12.83±1.89
ΔT [h]: describes the difference in time necessary to reach half-maximal OD600 when a
strain was expressing native WT-Syn or transformed with the control plasmid.
SEM: standard error of the mean obtained from three independent growth curves.
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pathway [53] and the mutant missing Doa4, the deubiquitylating
enzyme that recuperates ubiquitin from endocytosed material [54].
Taken together, the data conﬁrmed that endocytosis mutants, which
are affected in post-vesicle-internalization steps and therefore fail to
properly deliver endocytosed material to the vacuole, share a
phenotype of enhanced α-Syn phosphorylation and increased α-Syn
toxicity. Next, we introduced the deletion of YCK1 in the vps21Δ or
vps28Δ strains. As described above, the deletion of YCK1 reduced α-
Syn toxicity presumably by lowering the endocytic rate. However, this
deletion could not prevent the toxicity enhancement conferred by the
lack of Vps21 or Vps28, indicative that post-vesicle-internalization
defects have a major impact onα-Syn toxicity (Table 1). The latter was
further exempliﬁed upon analysis of the vps45Δ mutant. The Vps45
protein is not required for delivery of endocytosed material to the
vacuole but is essential for fusion of Golgi-derived vesicles to the
prevacuolar compartment and transport of Cvt vesicles from the
cytoplasm to the vacuole [55,56]. In contrast to the endocytosis
mutants, the vps45Δ strain combined reduced α-Syn phosphorylation
with an α-Syn toxicity that was only slightly higher than that
observed in the wild type strain (Table 1, Fig. 4). This observations
pointed us to another important aspect. Since the deletion of VPS45
blocks biosynthetic trafﬁcking, several of the soluble vacuolar
proteases and vacuolar membrane proteins do not reach the
degrading compartment [55]. Therefore, it appears that there is no
apparent correlation between reduced vacuolar degrading activity
and α-Syn toxicity. In fact, careful re-examination of the wild type
strain BY4741 and mutants retrieved from our screening failed to
show that the WT-Syn–EGFP fusion protein entered into the vacuolar
lumen, even not under conditions of sustained overexpression or
conditions where EGFP fusions of yeast permeases, such as the
ammonium permease Mep2, readily entered the vacuole (data not
shown). Moreover, examination of a yeast pep4Δ mutant that fails to
degrade proteins in the vacuole because it lacks the Pep4 protease did
not reveal accumulation or enhanced inclusion formation of WT-Syn–
EGFP, but a similar expression level and plasma membrane localiza-
tion of the fusion protein as in the wild type strain (data not shown).
If not reduced vacuolar degradation, then what caused the
combined phenotype of enhanced α-Syn phosphorylation or α-Syn
toxicity? We reasoned that this could be due to enhanced recycling of
α-Syn from endosomes back to the plasma membrane. The rationale
behind this is that several studies on endocytosis of yeast plasma
membrane proteins indicated recycling to be very rapid in mutants
that block trafﬁc along the vacuolar degradation pathway, resulting in
an apparent plasma membrane stabilization of permeases like Gap1
and Fur4 [57–59]. Studies on recycling identiﬁed the HOPS mutant
vps33Δ as a strain where endocytosed proteins, i.e. the v-SNARE and
VAMP ortholog Snc1, remain trapped in a hypophosphorylated form in
recycling-incompetent endosomes [58]. Hence, to substantiate that
recycling may as well apply to α-Syn, we analyzed the vps33Δmutant
in more detail. As expected, WT-Syn–EGFP was mostly found in
inclusions in this strain (Figs. 2 and 5), yielding more than 90% of the
mutant cells with inclusions (Fig. 1 and Table S1—Supplemental
material). Analysis of mutant α-Syn showed a similar phenotype for
EGFP-tagged A53T, while for EGFP-tagged A30P fewer cells with clear
inclusion were found (Fig. 5). Hence, inclusion formation of wild type
and mutant α-Syn in the vps33Δ mutant appeared to correlate with
the plasma membrane binding properties of the proteins.
Despite the high score of inclusion formation with WT-Syn, the
vps33Δ strain displayed a lower ΔT value as the congenic wild type
strain, indicative that there was decreased toxicity upon expression of
native WT-Syn and underscoring the lack of correlation between α-
Syn toxicity and the number of cells with inclusion (Table 1).
Furthermore, examination of the phosphorylation level of native
WT-Syn conﬁrmed that the protein accumulated in its hypopho-
sphorylated form in this mutant (Fig. 4). Intriguing is that the vps33Δ
strain was reported not to have discernible vacuoles and to secrete
vacuolar proteases [60,61]. Thereby, our analysis again conﬁrmed the
lack of correlation between reduced vacuolar degradation and
elevated levels of α-Syn phosphorylation or toxicity.
To substantiate that enhanced α-Syn recycling does explain the
increased α-Syn toxicity characteristic for post-vesicle-internaliza-
tion mutants, we deleted VPS33 in the vps21Δ and vps28Δ mutants.
As expected, this led to a signiﬁcant reduction of the α-Syn toxicity
since the vps21Δvps33Δ and vps28Δvps33Δ double mutants displayed
ΔT values comparable to that of the single vps33Δ deletion mutant
(Table 1).
3.4. N-terminal acetyltransferases determine α-Syn membrane binding
speciﬁcities
Apart from studies on ser-129 phosphorylation, Anderson et al.
[35] reported the presence of N-terminal acetylated α-Syn in brain
cytosol and Lewy bodies. We retrieved the catalytic subunit Nat3 of
the N-terminal acetyltransferase NatB complex from our screening.
This protein shows most homology to human NAT5. In addition to
NatB, yeast cells encode two other N-terminal acetyltransferases, i.e.
NatA and NatC, which are characterized by the catalytic subunits Ard1
and Mak3 [62]. Although N-terminal acetylation is a common
modiﬁcation of eukaryotic proteins, the biological role is far from
understood but may be subtle and not absolute for most proteins. To
demonstrate the importance of N-terminal acetylation for α-Syn
localization, we compared the cellular distribution of the WT-Syn–
EGFP fusion protein in several Nat mutants. As shown in Fig. 2 and
quantiﬁed in Fig. 6A, disruption of NatB activity by deletion of either
the catalytic subunit, Nat3, or the auxiliary subunit, Mdm20, led to a
more cytoplasmic localization of WT-Syn–EGFP, demonstrating that
NatB is indispensable for the proper plasmamembrane targeting ofα-
Syn. In contrast, disruption of NatA or NatC by deletion of Ard1, Nat1
or Mak3, or disruption of Nat4, known to be involved in histone
acetylation [63], did not seem to have a major effect since the fusion
protein remained predominantly localized at the plasma membrane,
similar as in the wild type strain. These data are in line with the
substrate speciﬁcities attributed to the different yeast N-terminal
acetyltransferases. For NatB this comprises Met-Glu and Met-Asp
Fig. 5. Accumulation of α-Syn in recycling-incompetent endosomes in the vps33Δ mutant. Fluorescence microscopic visualization and intracellular localization of EGFP and EGFP-
tagged WT-Syn, A30P or A53T in vps33Δ mutant cells grown for 18 h in selective medium containing 20 μM methionine.
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termini [62], the latter corresponding to the N-terminus of α-Syn,
making this protein indeed a potential substrate. Interestingly, only
the deletion of Nat3 but not that of other transferases caused a
signiﬁcant reduction in the α-Syn phosphorylation level (Fig. 6B),
which is in agreement with the data described above suggesting that
phosphorylation of α-Syn occurs, at least in part, when the protein is
plasma membrane associated.
Analysis of the growth proﬁles demonstrated that expression of
native WT-Syn did not signiﬁcantly inﬂuence the growth of the nat3Δ
mutant, in contrast to the other nat mutants (Fig. 6C, Table 1). This
suggested that NatB could be involved in the process leading to
toxicity of α-Syn. To elaborate on this, we took a closer look to several
phenotypic parameters known to be dependent on NatB. Mutants
carrying a NAT3 or MDM20 deletion were reported to have a
mitochondrial inheritance defect [64,65]. However, a comparative
analysis of the wild type BY4741 strain with or without expression of
native WT-Syn did not reveal differences in the distribution of
mitochondria from the mother to daughter cells (data not shown),
excluding that α-Syn expression would primarily interfere with
mitochondrial inheritance. Yeast nat3Δ mutants also lack stable
actin ﬁlaments due to the loss of acetylation of actin and tropomyo-
sin-1 [65,66]. Though several genes involved in actin cytoskeleton
organization were indeed recovered from our screen, including the
tropomyosin1 gene TPM1, the corresponding mutants clearly show α-
Syn inclusions while cells deprived from NatB activity are character-
ized by a diffuse cytoplasmic localization of α-Syn. This makes it
Fig. 6. Inﬂuence of N-terminal acetylation on localization, phosphorylation and toxicity ofα-Syn. (A) Amount of cells with predominant plasmamembrane localization or cytoplasmic
localization of WT-Syn–EGFP in cultures from the wild type yeast BY4741 or congenic mutants lacking catalytic or regulatory components of N-terminal acetyl transferases as
indicated. (B) Quantiﬁcation of the relative amount of ser-129 phosphorylation of native WT-Syn in BY4741 and congenic nat1Δ, nat3Δ or yir042cΔ mutants. (C) Growth proﬁles of
the BY4741 wild type strain (w , ♦) and congenic mutants lacking Nat1, Nat3 or Yir042c (▵, ▴) transformed with an empty plasmid (w , ▵) or a construct allowing for expression of
native WT-Syn (♦, ▴). All data represent the mean of at least three independent experiments. (D) Endocytosis of FM4-64 in the BY4741 wild type strain and the nat3Δmutant each
transformed with a control plasmid (ev) or expressing native WT-Syn. The dye was added to the cells at 0 °C. Cells were then shifted to room temperature to start endocytosis and
pictures were taken after 45 min. (E) Quantiﬁcation of cells with multi-vesicular vacuoles. Given are the percentages obtained for the BY4741 wild type strain or the nat3Δmutant
transformed with a control plasmid (ev) or expressing native WT-Syn, A30P or A53T as indicated.
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unlikely that NatB-dependent defects in the actin cytoskeleton would
be a primary denominator for α-Syn toxicity, which is in line with the
conclusion drawn from an elaborate growth study stating that the
phenotypes of the nat3Δ mutant are not predominantly caused by
alterations in the actin cytoskeleton [67].
Cells deprived of Nat3 were additionally reported to have vacuolar
fusion defects [26]. To address whether such a phenotype is obtained
upon α-Syn expression, we monitored endocytosis of the ﬂuorescent
dye FM4-64 until a steady state was obtained. In wild type cells
transformed with the empty vector or expressing the A30P mutant,
FM4-64 staining resulted in visualization of a single or a few large
vacuoles within 20 min. In cells transformed with WT-Syn or A53T a
steady state was reached only 45 min. after internalization of the
ﬂuorescent dye and many cells displayed staining of multiple
clustered small vacuoles (Fig. 6D, E). In the nat3Δ mutant, the
difference between the control or cells expressing WT-Syn was not
that pronounced and although some vacuolar fusion defects were
evident in these strains, the amount of cells with such a defect was
comparable to the numbers obtained with A30P-expressing wild type
cells (Fig. 6D, E). Thus, deletion of NAT3 appears to prevent α-Syn-
induced vacuolar fusion defects. This is would be consistent with a
lower input into endocytosis as further suggested by the observation
that WT-Syn is more cytoplasmic in the nat3Δ mutant.
Next to NatB, our screening identiﬁed an additional putative
GCN5-related N-acetyltransferase (GNAT) encoded by YIR042c. Dele-
tion of this ORF often resulted in α-Syn–EGFP localization in vacuolar
membranes (Fig. 2), providing an additional conﬁrmation that α-Syn
is sorted along the vacuolar degradation pathway. In contrast to
disruption of Nat3, deletion of YIR042c did not affect α-Syn
phosphorylation or the level of α-Syn-mediated toxicity signiﬁcantly
when compared to the congenic wild type strain (Fig. 6B, C).
3.5. α-Syn binds to DRMs in yeast in an ergosterol-dependent manner
Recently, it was shown thatα-Syn can associatewith lipid rafts and
that this interaction is important to mediate the synaptic localization
in mouse brain [68]. Lipid rafts are enriched in cholesterol and
sphingolipids and are believed to correspond biochemically to so-
called DRMs (detergent-resistant membrane fractions) because they
are not readily solubilized in non-ionic detergents [69]. The
identiﬁcation in our screen of genes involved in synthesis of
sphingolipid and ergosterol, the yeast counterpart for cholesterol,
suggested thatα-Syn could interact with rafts also in yeast. To address
this issue, we expressed α-Syn as native or EGFP fusion in wild type
cells, solubilized the membranes in 0.2% Triton-X-100 at 0 °C and
separated the insoluble membranes by ﬂotation on an Optiprep
gradient. Western blotting of the different gradient fractions revealed
that a minor portion of both native as well as EGFP-fused WT-Syn is
recovered in the upper detergent-resistant fractions that also
contained Pma1, a known DRM-associated protein that served as
positive control (Fig. 7A). Immunodetectionwith the antibody speciﬁc
for phosphorylated ser-129 conﬁrmed the presence of minute
amounts of phosphorylated α-Syn in the same fractions. We then
also fractionated membranes obtained from cells expressing the
native A30P protein. In comparison to WT-Syn, the A30P mutation
decreases DRM association in yeast, which is consistent to the
observations made in cells of higher eukaryotes [68]. Finally, when
membranes were isolated from cells expressing native EGFP, this
soluble protein was solely present in fractions that separated more to
the bottom of the gradient.
To assess directly the role of ergosterol in the interaction of α-Syn
with DRMs in yeast, we analyzed different mutants affected in
ergosterol biosynthesis, i.e. erg6Δ, erg28Δ and erg24Δ. In contrast to
the erg24Δ strain, the erg6Δ and erg28Δmutants were both recovered
from our screening as they combined plasma membrane localization
with accumulation of inclusions of WT-Syn–EGFP (Table S1—Supple-
mental material). Indeed, ERG6 encodes the ER-resident delta-24-
sterol methyltransferase required for C-24 methylation of zymosterol,
while ERG28 encodes a tethering function required to form the
biosynthetic complex at the ER. Both genes are not essential under
standard growth conditions, indicative that yeast cells tolerate some
degree of difference in ergosterol biosynthesis [70,71]. In contrast,
ERG24 encodes the sterol C-14 reductase, which is essential for
aerobic growth on rich medium but not on synthetic medium, the
growth condition used in this study [70]. Interestingly, deletion of
ERG6 or ERG28 had only a moderate effect on the presence of WT-
Syn–EGFP in the upper detergent-resistant fractions, while deletion of
ERG24 displaced WT-Syn–EGFP to the more dense gradient fractions
and thus abrogated an interaction between α-Syn and DRMs (Fig. 7B).
This observation is in line with data obtained in neuronal cells and
mice on the cholesterol requirement for the interaction of α-Syn to
membrane rafts [68,72]. As expected, the deletion of ERG24 did not
affect the association of Pma1 with DRMs (Fig 7B), which is consistent
with the ﬁnding that this association is largely independent of the
ergosterol content in rafts [73]. Note, however, that α-Syn still
localized to the plasmamembrane in the erg24Δ strain, indicative that
besides lipid rafts the protein must also interact with other
membranous components (Fig. 7C). Furthermore, the erg6Δ and
erg24Δmutants displayed similar α-Syn phosphorylation levels (data
not shown), suggesting that α-Syn phosphorylation occurs before the
interaction with DRMs or that the latter is not a prerequisite α-Syn
phosphorylation.
Finally, to investigate whether or not the reduced plasma
membrane binding of α-Syn in NatB-deﬁcient cells would be due to
an altered lipid raft interaction, we also analyzed the nat3Δmutant. As
shown in Fig. 7B, WT-Syn–EGFP was still present in DRM fractions
isolated from nat3Δ cells with levels comparable to those obtained for
the congenic wild type strain. This suggests that N-terminal acetyla-
tion of α-Syn is not essential for its interaction with DRMs but solely
for the interaction with other membrane constituents.
4. Discussion
Although the precise function of α-Syn is still not clear, studies in
mammalian cell lines and transgenic mice suggested a role in synaptic
vesicle dynamics. Also in yeast, several observations linked α-Syn to
vesicular trafﬁc. Expression of WT-Syn or the A53T mutant were
reported to retard endocytosis [6,7] and to block ER-to-Golgi transport
thereby causing ER-stress [9]. In addition, genes with a function in
vesicular trafﬁc in yeast have been identiﬁed as modulators of α-Syn-
induced toxicity [9,10]. The latter demonstrated that interference with
vesicular trafﬁc could underlie the observed toxicity of α-Syn in yeast
cells. However, there are several closely connected vesicle trafﬁcking
routes and it remains to be elucidated how and where α-Syn
intercepts with vesicular transport and how this may lead to toxicity
in yeast. This is further illustrated by the retrieval with our screen of
mutants lacking components of the tethering and sorting complexes
TRAPP (TRAnsport Protein Particle), COG (Conserved Oligomeric
Golgi), GARP/VFT (Golgi-Associated Retrograde Protein/Vps Fifty
Three), ESCRT, HOPS and the Class C Vps complex, which deﬁne
different trafﬁcking routes in yeast [53] and which were all found to
display mislocalization and enhanced inclusion formation of α-Syn.
Toxicity in yeast is mainly observed with WT-Syn and the A53T
mutant and to a much lesser extent with the A30P mutant [6,7]. This
difference closely reﬂects the membrane binding capacity of the
proteins, sinceWT-Syn and A53T were found to initially localize at the
plasmamembranewhere they start to form inclusions, while the A30P
mutant was shown to remain predominantly cytoplasmic without
inclusion formation [6–8]. Dixon et al. showed that delivery ofWT-Syn
and A53T to the plasma membrane occurs through association with
vesicular intermediates of the secretory pathway [8]. Sorting into
secretory vesicles and correct targeting to the plasma membrane in
ht
tp
://
do
c.
re
ro
.c
h
9
yeast requires the incorporation of plasma membrane resident
proteins into detergent-insoluble domains or lipid rafts, a process
that occurs before exit of the Golgi apparatus [73,74]. In mouse brain,
α-Syn was indeed reported to associated to lipid rafts [68] and we
provide the ﬁrst evidence that also in yeast a minor fraction of native
and EGFP-fused α-Syn co-puriﬁes with the detergent-insoluble
membrane domains. Moreover, the interaction between α-Syn and
lipid rafts inmammalian cells was shown to be abrogated by depletion
of cholesterol or the introduction of the A30P mutation in α-Syn [68]
and the same parameters were found to determine the presence of α-
Syn in the detergent-resistant fractions of yeast membranes.
Recent studies described the blockage of ER-to-Golgi transport [9]
and accumulation of ER–Golgi transport vesicles and secretory
vesicles [15] as early phenomena underlying the α-Syn-mediated
growth defect in yeast. Hence, it is tempting to speculate that these
phenomena depend on the interaction of α-Syn with lipid raft
domains in the membranous compartments and vesicles. The
observation that the α-Syn mutant A30P combines a strongly reduced
DRM interaction with failure to form inclusions, to accumulate
vesicles or to induce a signiﬁcant growth defect, supports such a
dependency. For WT-Syn, however, our results were not that
conclusive since comparable amounts of the protein appear to be
present in DRMs fractions isolated fromwild type cells, whereWT-Syn
is mostly targeted to the plasma membrane, from the ergosterol
biosynthesis mutants erg6Δ and erg28Δ, which are both characterized
by enhanced α-Syn inclusion formation, or from the nat3Δ mutant,
Fig. 7. Lipid raft interaction ofα-Syn. (A) Interaction to lipid rafts of nativeWT-Syn, the native A30Pmutant or thewild typeα-Syn fused to EGFP (WT-syn–EGFP) in the BY4741 strain.
Detection ofα-Syn in the different samples was done using the polyclonal α-Syn antibody (a, c) or with themonoclonal phospho-ser129 antibody (b). Also shown are the positive (d)
and negative (e) controls with the detection of Pma1 or EGFP, respectively. (B) Interaction to lipid rafts of WT-Syn (a) or Pma1 (b) in the speciﬁed mutants affected in ergosterol
biosynthesis (a, b) or in the nat3Δmutant (c). Extracts were prepared in the presence or absence of 0.2% Triton-X-100 at 0 °C as indicated. The quantiﬁcation displays the amount ofα-
Syn bound to DRMs (fractions 3, 4, and 5) versus the soluble fraction (fractions 7 to 11). The results are relative to the data obtained with the wild type strainwhere the amount of α-
Syn present in DRM fractions is set at 100%. (C) Fluorescence microscopic visualization and intracellular localization of EGFP-tagged WT-Syn in ergosterol biosynthesis mutants
grown for 18 h in selective medium containing 20 μM methionine.
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which displays a more cytosolic localization of WT-Syn. Nonetheless,
there are differences between the strains for the distribution of WT-
Syn over the various optiprep fractions, including those that contain
DRMs, andwe cannot rule out completely that these differencesmight
be important. In addition, WT-Syn failed to properly interact with
DRMs when expressed in the erg24Δ mutant and although we still
observed plasma membrane localization of the WT-Syn–EGFP fusion
protein, the latter failed to form inclusions under the conditions used
for the mutant collection screening. It should also be noted that only a
minimal portion of WT-Syn expressed in yeast co-puriﬁes with DRMs
and thus, that the majority of the protein is found in the detergent
soluble fractions. This makes WT-Syn different from typical lipid raft
associated proteins and it possibly indicates that the association of
WT-Syn with DRMs could be indirect via an interaction with another
protein. In mammalian cells, α-Syn was recently shown to interact
with the septin, Sept4, a presynaptic scaffold present in lipid rafts that
also binds other proteins like the dopamine transporter, syntaxin and
SNAP25. Interestingly, this study revealed Sept4 to function as a
suppressor for α-Syn phosphorylation, oligomerization and neuro-
toxicity [75] and it was suggested Sept4 plays an important role in
vesicle assembly and release [76].
Our data established that α-Syn is phosphorylated at ser-129 in
yeast cells and that this is dependent on the CK-I and CK-II casein
kinases. Again, this is in line with data obtained from studies in higher
eukaryotic systems [30,31] but while these and other studies [34,35]
indicated that α-Syn phosphorylation is an early event in the
pathology of Parkinson's disease, the yeast model only conﬁrmed
that reducing the ser-129 phosphorylation by deletion of the plasma
membrane-localized CK-I kinase Yck1 or Yck2 coincided with a drop
of α-Syn-mediated growth retardation or toxicity. The depletion of
the CK-II kinase activity did not ameliorate cell growth but this may
not be surprising since CK-II is important for the transduction of
survival signals, both in mammalian and yeast cells [25].
Interestingly, both Yck1 and Yck2 are known to phosphorylate and
thereby stimulate the internalization of several yeast plasma mem-
brane proteins, including the pheromone receptors Ste2 and Ste3
[29,36,77], the uracil permease Fur4 [37,38] and themaltose permease
Mal61 [78]. In addition, Yck1 also associates to the plasma membrane
glucose sensor Rtg2 to promote the phosphorylation and degradation
of Mth1 and Std1, two proteins required for the regulation of glucose
transporters in yeast [79]. This led us to assume that the reduced
toxicity of α-Syn in the yck1Δ and yck2Δ mutants could relate to a
lower endocytic rate. This assumption was further supported by the
observation that also mutants lacking other proteins involved in the
formation and internalization endocytic vesicles, i.e. the clathrin
heavy chain Chc1, the amphiphysin-homolog Rvs161 or the SGK2-
homolog Ypk2, displayed reduced α-Syn toxicity as well. In contrast,
mutants with post-vesicle-internalization defects were characterized
by enhanced α-Syn toxicity. Together, these data suggest that in
addition to obstruction of ER-to-Golgi transport and the secretory
pathway, α-Syn toxicity must also arise from interference with
endocytic processes. As such, α-Syn behaves similar to expanded
polyQ Huntingtin fragments, which also gain toxicity in yeast by
obstructing early steps of endocytosis [80,81].
The increased α-Syn toxicity in mutants with post-vesicle-
internalization defects appeared to be speciﬁc as it did not occur
with the vps45Δmutant, lacking a protein involved in trafﬁc between
Golgi and the prevacuolar compartment and transport of Cvt vesicles
from the cytoplasm to the vacuole [55,56]. One could argue that a
block in endocytosis prevents efﬁcient vacuolar degradation of α-Syn
and other proteins and that this would be the cause of enhanced α-
Syn toxicity in the post-vesicle-internalization mutants. However, the
toxicity of α-Syn was similar in wild type cells and in the vps45Δ
mutant, which fails to properly deliver proteases to the vacuole [55],
and it was even reduced in the vps33Δ mutant, which does not have
discernible vacuoles [60,61]. This makes it unlikely that the lack of
vacuolar degradation capacity would be the primary reason for the
observed increased α-Syn toxicity. Moreover, in none of the strains
analyzed in our screening we observed WT-Syn–EGFP to enter the
vacuolar lumen, an observation that is in line with data from a study
recently performed by Witt and coworkers. They identiﬁed Ypp1, a
protein involved in receptor-mediated endocytosis, as multicopy
suppressor of the toxicity triggered by A30P when yeast cells are
challenged with peroxide-induced oxidative stress. In unraveling the
molecular mechanism underlying this suppression, they showed that
Ypp1 binds to A30P and drives this protein to vacuolar degradation via
the endocytic pathway. Interestingly, Ypp1 does not interact withWT-
Syn and in consequence fails to induce its vacuolar degradation or to
rescue yeast cells from the toxicity induced by WT-Syn [82].
Studies on the yeast amino acid transporter Gap1 and the uracil
permease Fur4, indicated that these proteins gradually dissociate from
DRMs during trafﬁcking along the endocytic pathway to recycle back
to the plasma membrane [74,83]. Interestingly, yeast mutants with
post-vesicle-internalization defects have higher rates of recycling and
therefore display an apparent stabilization of transporters, permeases
and receptors at the plasma membrane [57–59]. Our data with the
vps33Δ mutant indicate that recycling also applies to α-Syn and that
it underlies, at least in part, α-Syn toxicity in yeast cells. The vps33Δ
mutant is known to have recycling deﬁciencies [58] and it was the
only yeast strain with a post-vesicular-internalization defect that did
not display enhancedα-Syn toxicity levels and this despite the highest
score for inclusion formation of all mutants tested. Furthermore, the
additional deletion of VPS33 in mutants with a post-vesicle-
internalization defects counteracted the α-Syn-induced growth
defect.
When compared to the congenic wild type strain, mutants affected
in endocytosis steps downstream of vesicle internalization were
characterized by enhanced ser-129 phosphorylation of α-Syn. In
contrast, the vps33Δ mutant kept α-Syn trapped as a hypopho-
sphorylated protein, similar to what has been reported for the v-
SNARE Snc1 [58]. This implies that recycling allows for accumulation
of phosphorylated α-Syn. Although this aspect was not studied in
detail, it is tempting to speculate that this is due to phosphorylation of
the accumulated α-Syn at the plasma membrane by Yck1 and Yck2.
Accumulation at the plasma membrane would also allow to reach the
critical concentration of α-Syn necessary for self-assembly and
inclusion formation, a phenomenon we and others demonstrated to
initiate at the plasma membrane [7,8]. Here we should mention that
there is still a controversy whether or not α-Syn ﬁbrilization occurs in
yeast cells. Indeed, while we previously reported that native and
EGFP-tagged α-Syn formed thioﬂavin-S positive and thus amyloid-
like aggregates [7], it was more recently argued based on EM studies
that the α-Syn accumulations do not contain ﬁlamentous structures
but solely clusters of membranous vesicles [15]. Whatever the nature
of the inclusions, their formation depends on the binding of α-Syn to
membranes. In this context it is interesting to note that recent studies
in yeast suggested recycling to go along with changes in the lipid
content between the plasma membrane and endosomal membranes
[74,83], similar to observations made in mammalian cells where
sphingolipids are restricted to enter the lysosomal degradative
pathway but recycle back from endosomes to the cell surface [84,85].
To date, different recycling pathways have been described in yeast
and proteins can directly recycle from endosomes to the plasma
membrane or ﬁrst traverse through the Golgi system [57,58]. As such,
recycling could feed in and accelerate the toxic effect of α-Syn on ER–
Golgi trafﬁc previously described by Lindquist and coworkers [9].
In wild type yeast cells, we found WT-Syn and A53T, but not A30P,
to induce vacuolar fusion defects in wild type cells. Evidence that
vacuolar fusion defects underlie α-Syn-induced toxicity comes from a
recent study performed by Cooper and coworkers. They identiﬁed
several suppressors for the α-Syn-induced toxicity in yeast and this
included Ykt6, a v-SNARE protein that apart from a role in retrograde
ht
tp
://
do
c.
re
ro
.c
h
11
transport to the cis-Golgi has also an essential function in vacuolar
fusion [9,86–88]. Moreover, we showed that the disruption of the N-
acetyltransferase NatB partially suppressed this α-Syn-induced
vacuolar fusion defect and that this coincided with failure of α-Syn
to trigger toxicity in the nat3Δ mutant. Although we did not measure
acetylation of α-Syn directly, there is a good chance that α-Syn is
directly subject to N-terminal acetylation by NatB since its N-terminus
ﬁts with the proposed consensus sequence of Nat B substrates.
Moreover, α-Syn is N-terminally acetylated in neurons [35]. Whether
this means that N-terminal acetylation of α-Syn is required to trigger
the vacuolar fusion phenotype cannot be concluded as disruption of
NatB itself already inﬂuenced the phenotype to some extend.
Interestingly, disruption of NatB altered the intracellular localization
of WT-Syn from the plasma membrane to a more cytoplasmic
distribution and this went together with lowering ser-129 phosphor-
ylation of WT-Syn. Again this corroborated a link between plasma
membrane binding, phosphorylation and toxicity of α-Syn. Taken
together, it is feasible to state thatWT-Syn in the NatBmutant behaves
similarly as the clinical A30P mutant in wild type yeast cells. Hence, it
would be appealing to investigate whether WT-Syn and the A30P
mutant are differentially acetylated and whether possible differences
relate directly to the above described YPP1-induced vacuolar
degradation. Indeed, although the biological function of N-terminal
acetylation is not well understood, it was previously suggested to play
a crucial role in impeding protein turnover [89]. Note, however, that in
human brain the N-terminally acetylated protein is present in Lewy
bodies as well as brain cytosol [35], suggesting that themodiﬁcation is
not speciﬁc for the formation of insoluble α-Syn aggregates. However,
this does not exclude that N-terminal acetylation could be a trigger in
the process leading to the precursors of aggregates, i.e. the soluble α-
Syn protoﬁbrils. Also intriguing is the characterization of the putative
GCN5-related acetyltransferase (GNAT), Yir042c, as a protein prevent-
ing vacuolar membrane targeting of α-Syn. Several GNAT proteins
have been identiﬁed to date and subsets of this protein family are
known to have different substrate speciﬁcities [90]. So far, the role and
substrates of Yir042c are elusive but based on the observation that the
YIR0472c deletion results in binding of α-Syn to the vacuolar
membrane, we speculate that either the protein has a role in lipid
metabolism or that it acts as modulator of the lipid binding properties
of α-Syn.
Another important aspect disclosed by our analyses is that there is
no strict correlation between the percentage of cells that formed α-
Syn inclusions andα-Syn toxicity observed in the corresponding yeast
culture. For instance, for the ypk1Δ and the vps45Δ mutants 13% and
60% of the cells formed inclusions, respectively, and both strains
display enhanced α-Syn toxicity as compared to the wild type strain,
while conversely for the vps33Δ mutant we counted 93% inclusion-
positive cells but observed a lower α-Syn toxicity as in the wild type
strain. This indicates that self-assembly or inclusion formation of α-
Syn is not toxic per se but that it is rather the disruption of normal
membrane processes by α-Syn that determines its toxicity. A similar
conclusion was reached by Volles and Lansbury, who analyzed
randomly generated α-Syn mutants [91]. Based on their study,
toxicity in yeast cells solely correlated to the membrane binding
ability of α-Syn and not with the ﬁbrilization rate of the protein as
measured in vitro. Moreover, when expressed in the ﬁssion yeast
Schizosaccharomyces pombe, human α-Syn does not target the plasma
membrane and the protein is not toxic despite its extensive
aggregation [92].
To summerize, our data suggest the model depicted in Fig. 8 where
in addition to blockage of ER-to-Golgi transport and the secretory
pathway as previously described [9,15], α-Syn gains toxicity in yeast
upon its association with forming vesicles at the plasma membrane, a
process that is, at least in part, controlled by the plasma membrane
resident CK-I kinases. Thereby α-Syn enters the vacuolar degradation
pathway but since it is excluded to enter the vacuole, α-Syn recycles
from endosomes back to the plasmamembrane. This continuous cycle
might eventually lead to saturation and blockage of endocytosis and
vesicular trafﬁcking routes that merge with the endocytic protein
sorting machinery. Thus, it appears that the properties ascribed to α-
Fig. 8. Interference ofα-Synwith vesicular trafﬁcking in yeast. Shown are different vesicular trafﬁcking routes in yeast and the tethering and sorting complexes involved (TRAPP, COG,
GARP, ESCRT, HOPS, Exocyst and the Class C Vps complex). Expression ofα-Syn in yeast affects vesicular trafﬁc at different stages as highlighted in the text boxes, thereby leading to a
blockage of ER-to-Golgi transport and the secretory pathway, retardation of endocytosis, enhanced recycling and vacuolar fusion defects.
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Syn for the control of vesicular dynamics and vesicular recycling in
neurons [3–5] are maintained when the protein is expressed in yeast,
making the latter a prime model to study the biology and
pathobiology of α-Syn.
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